[PHARMA] QoQ Annualized Quarter Result on 30-Sep-2021 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Sep-2021 [#3]
Profit Trend
QoQ- 56.85%
YoY- 156.28%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 3,446,552 3,848,696 4,815,015 5,471,062 3,941,244 3,173,996 2,725,071 17.00%
PBT 83,920 149,756 277,075 202,649 107,536 126,096 35,793 76.76%
Tax -24,380 -34,332 -104,870 -86,596 -34,104 -34,784 -9,524 87.45%
NP 59,540 115,424 172,205 116,053 73,432 91,312 26,269 72.80%
-
NP to SH 56,912 110,936 172,150 115,566 73,680 92,544 27,489 62.65%
-
Tax Rate 29.05% 22.93% 37.85% 42.73% 31.71% 27.59% 26.61% -
Total Cost 3,387,012 3,733,272 4,642,810 5,355,009 3,867,812 3,082,684 2,698,802 16.39%
-
Net Worth 406,087 413,947 450,411 391,428 357,275 355,919 337,298 13.20%
Dividend
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Div 34,058 41,918 121,768 75,056 60,200 41,872 28,761 11.96%
Div Payout % 59.84% 37.79% 70.73% 64.95% 81.71% 45.25% 104.63% -
Equity
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Net Worth 406,087 413,947 450,411 391,428 357,275 355,919 337,298 13.20%
NOSH 1,309,126 1,309,126 1,309,126 1,309,126 261,991 261,705 261,705 193.35%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 1.73% 3.00% 3.58% 2.12% 1.86% 2.88% 0.96% -
ROE 14.01% 26.80% 38.22% 29.52% 20.62% 26.00% 8.15% -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 263.10 293.80 367.74 417.92 301.16 1,212.81 1,042.20 -60.15%
EPS 4.34 8.48 13.15 8.83 5.64 35.36 10.51 -44.63%
DPS 2.60 3.20 9.30 5.73 4.60 16.00 11.00 -61.87%
NAPS 0.31 0.316 0.344 0.299 0.273 1.36 1.29 -61.44%
Adjusted Per Share Value based on latest NOSH - 1,309,126
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 239.14 267.04 334.08 379.60 273.46 220.22 189.08 17.00%
EPS 3.95 7.70 11.94 8.02 5.11 6.42 1.91 62.53%
DPS 2.36 2.91 8.45 5.21 4.18 2.91 2.00 11.69%
NAPS 0.2818 0.2872 0.3125 0.2716 0.2479 0.247 0.234 13.23%
Price Multiplier on Financial Quarter End Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 -
Price 0.595 0.755 0.74 0.835 5.29 3.26 5.00 -
P/RPS 0.23 0.26 0.20 0.20 1.76 0.27 0.48 -38.84%
P/EPS 13.70 8.92 5.63 9.46 93.96 9.22 47.56 -56.48%
EY 7.30 11.22 17.77 10.57 1.06 10.85 2.10 129.99%
DY 4.37 4.24 12.57 6.87 0.87 4.91 2.20 58.21%
P/NAPS 1.92 2.39 2.15 2.79 19.38 2.40 3.88 -37.51%
Price Multiplier on Announcement Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 19/08/22 20/05/22 17/02/22 19/11/21 20/08/21 21/05/21 17/03/21 -
Price 0.595 0.72 0.76 0.845 0.925 4.03 3.49 -
P/RPS 0.23 0.25 0.21 0.20 0.31 0.33 0.33 -21.44%
P/EPS 13.70 8.50 5.78 9.57 16.43 11.40 33.20 -44.66%
EY 7.30 11.76 17.30 10.45 6.09 8.77 3.01 80.80%
DY 4.37 4.44 12.24 6.79 4.97 3.97 3.15 24.46%
P/NAPS 1.92 2.28 2.21 2.83 3.39 2.96 2.71 -20.57%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment